Skip to content

MANAGEMENT TEAM


Kenneth W. HARLOW
Kenneth W. HARLOW Board member and CEO
Kenneth W. Harlow brings more than 25 years of experience in the SME biotech, biopharma, and life sciences sectors. He combines strong entrepreneurial leadership and business development capabilities with deep technical expertise in protein chemistry, bioprocessing, molecular biology, and in vitro diagnostics and assay development from holding various leadership positions at Exiqon and Zealand Pharma. Kenneth previously served as an Associate Professor at the University of Copenhagen’s Institute of Molecular Biology and holds a PhD in Biochemistry from the University of Illinois.

LinkedIn

Dr. Søren MORGENTHALER ECHWALD
Søren MORGENTHALER ECHWALD CSO
Soren Echwald is a seasoned professional with extensive experience in the life sciences and biotechnology sectors. Throughout his career, he has held various leadership positions, including roles at Exiqon and Anapa Biotech, where he contributed significantly to the development of innovative molecular diagnostic solutions. Soren's expertise spans molecular biology, genomics, and biotechnology, making him an asset to any organization focused on advancing scientific research and technology. Soren has a strong academic background, holding a PhD in Molecular Biology from the Technical University of Denmark.

LinkedIn

Magnus JÖNSSON
Magnus JÖNSSON CFO
Magnus Jönsson brings extensive expertise in finance and accounting, with 20 years of experience from PwC Sweden, where he served as a Partner between 2015-2021. At PwC, Magnus mainly worked as an Authorized Public Accountant with both public and private companies across a broad range of industries. His financial experience also includes being Head of Accounting at Orkla Sverige for two years. Magnus holds a Master’s degree in Business Administration from Lund University.

LinkedIn

Pete CORISH
Pete CORISH VP Business Development
Pete Corish has more than 20 years of experience in clinical laboratory diagnostics, point-of-care immunoassays, and molecular diagnostics. He has held senior commercial and technology leadership roles across the UK and US life sciences and IVD sectors, including at Alere, Oxford Gene Technology, and BBI Solutions, where he served as Chief Technology Officer. His expertise spans commercialization of innovative diagnostic technologies, strategic partnerships, licensing, and M&A. More recently, Pete has advised US-based growth investors targeting opportunities in Europe in addition to assisting Diagnostic and Life Science Tools start-ups on investment opportunities and commercial development. He holds a PhD in Molecular Genetics from the University of Cambridge.

LinkedIn

Niklas MÅRTENSSON
Niklas MÅRTENSSON Nanowire Platforms Director and co-founder
Niklas Mårtensson brings more than 10 years of experience and deep technical expertise in materials science, nanotechnology, and material optics. Prior to joining Aligned Bio, he held key engineering roles at Sol Voltaics, where he specialized in nanowire functionalization, alignment technologies, and monolayer thin-film manufacturing processes. His work has focused on the development and optimization of advanced nanomaterials and scalable production methods for high-performance applications. Niklas holds a Master’s degree in Physics from Linköping Institute of Technology.

LinkedIn

Dr. Karin BLUME
Karin BLUME Biomarker Product Technology Director
Karin Blume is a highly experienced professional in the field of biomarker assay development from proof of concept to fully validated tests using several instrument platforms including fully automated clinical systems to POC applications as well as custom assay development for CROs and pharma industry. Over the past 15 years, Karin held various R&D roles at Thermo Fisher Scientifc ImmunoDiagnostic Division, Becton Dickinson Bioscience and Svar Life Science. She holds a PhD in Immunology and Cell biology from the University of Tübingen.

LinkedIn